Adaptive Biotechnologies is a series c plus startup based in US. 1 investor tracked.
Based in the United States, Adaptive Biotechnologies is a startup. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Adaptive Biotechnologies is a biotechnology company that focuses on leveraging the adaptive immune system to develop diagnostics and therapeutics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.